| Entry |
|
| Name |
Smith-Lemli-Opitz syndrome |
| Description |
Smith-Lemli-Opitz syndrome is an autosomal recessive disorder caused by deficiency of 7-dehydrocholesterol reductase in cholesterol biosynthesis.
|
| Category |
Inherited metabolic disorder
|
| Brite |
Human diseases in ICD-11 classification [BR:br08403]
05 Endocrine, nutritional or metabolic diseases
Metabolic disorders
Inborn errors of metabolism
5C52 Inborn errors of lipid metabolism
H00161 Smith-Lemli-Opitz syndrome
Pathway-based classification of diseases [BR:br08402]
Lipid/glycolipid metabolism
nt06034 Cholesterol biosynthesis
H00161 Smith-Lemli-Opitz syndrome
|
| Pathway |
|
| Network |
|
| Gene |
|
| Other DBs |
|
| Reference |
|
| Authors |
Porter FD |
| Title |
Smith-Lemli-Opitz syndrome: pathogenesis, diagnosis and management. |
| Journal |
|
| Reference |
|
| Authors |
Yu H, Patel SB |
| Title |
Recent insights into the Smith-Lemli-Opitz syndrome. |
| Journal |
|
| Reference |
|
| Authors |
Correa-Cerro LS, Porter FD |
| Title |
3beta-hydroxysterol Delta7-reductase and the Smith-Lemli-Opitz syndrome. |
| Journal |
|
| Reference |
|
| Authors |
Wassif CA, Maslen C, Kachilele-Linjewile S, Lin D, Linck LM, Connor WE, Steiner RD, Porter FD |
| Title |
Mutations in the human sterol delta7-reductase gene at 11q12-13 cause Smith-Lemli-Opitz syndrome. |
| Journal |
|
| LinkDB |
|